DCGO · DocGo Inc.
$0.40
+0.00 (+0.15%)
At close · Oct 1
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 17, 2026
The latest filing states the doubt was alleviated.
“While these plans carry meaningful inherent risk to operations and involve a significant number of steps and components, the Company's management and the Board of Directors have evaluated these conditions in totality and believe it is probable that, when implemented, the plans will be sufficient to alleviate substantial doubt about the Company's ability to continue as a going concern for the twelve months following the issuance date.”View the 10-Q filed Aug 17, 2026
Market Cap
$39.27M
Shares
98.93M
Volume · Oct 1
134.7K
Avg daily vol (3M)
741.89K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.40
Open$0.38
Day$0.38–0.42
52W close$0.34–1.49
Avg vol 30d875K
Short int2.8M · 2.8% float · 4.8d
Short vol39%
Last earningsAug 17, 2026
DataDec 2020–Sep 2026
Filing10-Q · Aug 17
Up next
Next earnings call
Nov 22, 2026
Est · unconfirmed
· in 7 wks
filed Aug 17, 2026
call held Aug 17, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$294.72M
Trailing 12 months
Net income (TTM)
−$192.42M
Trailing 12 months
Revenue growth YoY
-8.7%
Year over year
Operating margin
-62.2%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-65.8%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$25.03M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-0.1%
Year over year · fewer shares
Price change (1Y)
-70.6%
Trailing year
Short interest
2.8%
Latest settlement · 4.8 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Bearish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 16.3 · calm
Equity put/call 0.53
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−37%
below
Price vs 50-day avg
−17%
below
RSI (14)
50
neutral
MACD trend
Positive
52-week position
5%
near low
Volume (OBV)
Bearish div.
distributing
Momentum
relative strength
1-month return
+4%
trailing
6-month return
−31%
trailing
YTD return
−54%
this year
Relative strength
−43%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-3% holders QoQ · +25 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.79% of float · ▲ +18.6% MoM · 4.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
119 holders — mid 3-yr range
Squeeze score
58
elevated · 0–100
Fundamentals
Revenue growth
−48%
Y/Y
EPS growth
−1122%
Y/Y
Free cash flow
$29.9M
Buyback
$62.0M
authorized
Balance sheet
$50.8M
net cash
Quant / Vol
risk profile
Volatility
88%
annualized · 1-yr
Max drawdown
−77%
past year
ATR
8.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Aug 17, 2026
full-year 2026
Revenues
Initiated
$305M – $310M
prior FY $322.2M
midpoint −4.6% Y/Y
full-year
Adjusted EBITDA loss
Non-GAAP
$17M – $22M
Guided vs delivered
· last 2 settled
Revenue
Full-year 2024
guided $600M – $650M
$616.56M
In line
Full-year 2023 revenue guidance
Full-year 2023
guided $615M – $625M
$624.29M
In line
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−37%
Bearish
Price vs 50-day avg
−17%
Bearish
RSI (14)
50
Neutral
MACD trend
Positive
Bullish
52-week position
5%
Bearish
Volume (OBV)
Bearish div.
Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-3% holders QoQ · +25 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.79% of float · ▲ +18.6% MoM · 4.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
119 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $0
Now $0 · 5%
Range high $1
vs 200-day avg -37%
vs 50-day avg -17%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | -$6.3M | Q2 FY2026 | — |
GAAP → non-GAAP reconciliationGAAP Net (loss) income (GAAP) -$18M
+$0.1M Net interest expense
+$0.1M Income tax (benefit) expense
+$2.7M Depreciation and amortization
-$0.1M Other expense (income)
+$2.7M Non-cash stock compensation
+$6.2M Non-recurring expense
= Adjusted EBITDA -$6.3M
|
|||
| Average trip price | $426 | the three months ended June 30, 2026 filing | — |
| Hicuity trailing 12-month adjusted EBITDA non-GAAP | 4.5M | trailing 12-month basis | — |
| Hicuity trailing 12-month revenue | 65M | trailing 12-month basis | — |
| patients assigned by the Company's payer and provider partners to engage for care gap closure se | 1.7M | Q2 FY2026 | — |
| U.S. trip volumes | 80,447 | the three months ended June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
DCGO
this stock
DocGo Inc.
|
$39.27M | -54.5% | -47.7% | — | 2.8% |
|
HCA
HCA Healthcare, Inc.
|
$96.64B | -8.6% | +7.1% | 15.0 | 2.9% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$29.92B | -11.6% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$20.91B | +28.6% | +0.9% | 10.0 | 2.5% |
|
EHC
Encompass Health Corp
|
$12.18B | +14.5% | +10.5% | 20.1 | 3.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| DCGO | +10.4% | +3.6% | -30.7% | +4.9% | -54.5% |
| SPY | -0.7% | +0.1% | +12.2% | -0.6% | +11.8% |
| vs SPY | +11.1% | +3.5% | -42.9% | +5.5% | -66.3% |
Capital returns
Buyback programs
· 2 active
· as of Aug 5, 2024
Authorized (total)
$62.00M
Spent (derived)
—
Remaining
—
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.